文献速递肿瘤 PET/CT

转移性去势抵抗性前列腺癌患者18F-FDHT摄取的简化定量方法评估

Assessment of Simplified Methods for Quantification of 18F-FDHT Uptake in Patients with Metastatic Castration-Resistant Prostate Cancer.
PubMed 文献 · J Nucl Med · 2019-03-08

结果显示18F-FDHT动力学最佳描述为不可逆两组织室模型,SUVAUC,PP与Patlak Ki相关性极佳(R2>0.9),且简化方法重复性优于完整动力学参数。

要点

  • SUVAUC,PP与不可逆两组织室模型分析相关性近完美,可用于全身PET/CT的18F-FDHT摄取准确量化。
  • SUVBW与Ki相关性中等(R2=0.70),经性激素结合球蛋白校正后SUVSHBG相关性改善(R2=0.88)。
  • 简化方法的重复性系数<28%,优于完整动力学模型的>36%。

核心结论

  • 18F-FDHT在mCRPC患者中的动力学最佳描述为含血容量参数的不可逆两组织室模型。
  • SUVAUC,PP与不可逆两组织室模型分析相关性近完美,可用于全身PET/CT的18F-FDHT摄取准确量化。
  • 当需要更简单扫描方案和可接受准确性时,SUVSHBG可作为更简便的18F-FDHT摄取定量方法。

研究设计与样本

  • 14例患者接受两次30分钟动态18F-FDHT PET/CT扫描并静脉采血。
  • 6例子集行动脉采血和动态15O-H2O扫描。

主要发现

  • 用图像衍生输入函数联合静脉样本数据替代连续代谢校正动脉血浆输入函数,获得的Ki结果相似(R2=0.98)。
  • Patlak Ki与SUVAUC,PP相关性极佳(R2>0.9)。
  • SUVBW与Ki相关性中等(R2=0.70),SUVSHBG与Ki相关性改善(R2=0.88)。
  • 完整动力学模型参数的重复性系数>36%,简化方法<28%。

临床怎么用

  • 在全身PET/CT扫描中,可采用SUVAUC,PP对18F-FDHT摄取进行准确量化。
  • 若扫描方案更简单且对准确性要求不高,可考虑使用SUVSHBG定量18F-FDHT摄取。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

18F-fluorodihydrotestosterone (18F-FDHT) PET/CT potentially provides a noninvasive method for assessment of androgen receptor expression in patients with metastatic castration-resistant prostate cancer (mCRPC). The objective of this study was to assess simplified methods for quantifying 18F-FDHT uptake in mCRPC patients and to assess effects of tumor perfusion on these 18F-FDHT uptake metrics. Methods: Seventeen mCRPC patients were included in this prospective observational multicenter study. Test and retest 30-min dynamic 18F-FDHT PET/CT scans with venous blood sampling were performed in 14 patients. In addition, arterial blood sampling and dynamic 15O-H2O scans were obtained in a subset of 6 patients. Several simplified methods were assessed: Patlak plots; SUV normalized to body weight (SUVBW), lean body mass (SUVLBM), whole blood (SUVWB), parent plasma activity concentration (SUVPP), area under the parent plasma curve (SUVAUC,PP), and area under the whole-blood input curve (SUVAUC,WB); and SUVBW corrected for sex hormone-binding globulin levels (SUVSHBG). Results were correlated with parameters derived from full pharmacokinetic 18F-FDHT and 15O-H2O. Finally, the repeatability of individual quantitative uptake metrics was assessed. Results: Eighty-seven 18F-FDHT-avid lesions were evaluated. 18F-FDHT uptake was best described by an irreversible 2-tissue-compartment model. Replacing the continuous metabolite-corrected arterial plasma input function with an image-derived input function in combination with venous sample data provided similar Ki results (R2 = 0.98). Patlak Ki and SUVAUC,PP showed an excellent correlation (R2 > 0.9). SUVBW showed a moderate correlation to Ki (R2 = 0.70, presumably due to fast 18F-FDHT metabolism. When calculating SUVSHBG, correlation to Ki improved (R2 = 0.88). The repeatability of full kinetic modeling parameters was inferior to that of simplified methods (repeatability coefficients > 36% vs. < 28%, respectively). 18F-FDHT uptake showed minimal blood flow dependency. Conclusion:18F-FDHT kinetics in mCRPC patients are best described by an irreversible 2-tissue-compartment model with blood volume parameter. SUVAUC,PP showed a near-perfect correlation with the irreversible 2-tissue-compartment model analysis and can be used for accurate quantification of 18F-FDHT uptake in whole-body PET/CT scans. In addition, SUVSHBG could potentially be used as an even simpler method to quantify 18F-FDHT uptake when less complex scanning protocols and accuracy are required.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Kramer GM, Yaqub M, Vargas HA, et al. Assessment of Simplified Methods for Quantification of 18F-FDHT Uptake in Patients with Metastatic Castration-Resistant Prostate Cancer. J Nucl Med. 2019. PMID: 30850488. doi:10.2967/jnumed.118.220111

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。